BackEntero Therapeutics Overview

Entero Therapeutics Net Income

Profitability analysis for ENTO.

Quarterly Net Income

-$3.44M
173% YoY

As of Mar 2026

Annual Net Income (TTM)

-$8.73M
64.91% YoY

Trailing 12 months ending Mar 2026

Average Net Income (Comparison Companies)

Loading

Net Income History

Loading

Net Income Comparison

Loading

Annual Net Income Growth Rate (%)

Loading...

Annual Net Income Growth (Absolute)

Loading...